7022 Typo bargain-Results for Sutro on ebay

Related search words:

You are here: Main category >

Just how it functions:

Auctions on ebay, with typing errors in heading or description no one could situate with routine search. Our typo search understands this and also looks for precisely these public auctions. Therefore you have the possibility to discover a little-noticed misspelled item with simply a couple of quotes at an economical price.
With Spelling mistakes & Misspellings you can find some real deals on ebay.com!

misspelled items of Sutro:

With term Sutro the following 56 typos were generated:
autro, cutro, dutro, eutro, qutro, s6tro, s7tro, s8tro, shtro, sitro, sjtro, sktro, sotro, ssutro, stro, sturo, su4ro, su5ro, su6ro, sudro, sufro, sugro, suhro, suro, surro, surto, sut3o, sut4o, sut5o, sutdo, suteo, sutfo, sutgo, suto, sutor, sutr, sutr0, sutr8, sutr9, sutri, sutrk, sutrl, sutroo, sutrp, sutrro, sutru, sutto, suttro, suutro, suyro, sytro, ustro, utro, wutro, xutro, zutro

News for Sutro

Sutro Biopharma Reports Third Quarter 2018 Financial Results
-- STRO-001 Received Orphan Drug Designation for Treatment of Multiple Myeloma -- STRO-002 to Begin Phase 1 Trial for Patients with Ovarian and Endometrial Cancers in Early 2019 SOUTH SAN ...

Sutro on go with Phase 1 study of STRO-002 in ovarian & endometrial cancers; shares up 1%
Thinly traded micro cap Sutro Biopharma (STRO +1.3%) is up, albeit on less than 9K shares, following its announcement that the FDA has signed off on its IND clearing the way for a Phase 1 clinical ...

Herb Caen lives on — via Twitter and a faraway lover of San Francisco
“A city is not gauged by its length and width, but by the broadness of its vision and the height of its dreams.” On the Sutro tower when it was built: "I keep waiting for it to stalk down the hill and ...

FDA signs off on IND for Sutro's ovarian, endometrial cancer drug
The FDA has signed off on Sutro Biopharma's investigational new drug application for STRO-002, being developed as a treatment for patients with ovarian and endometrial cancers. The company intends to ...

Sutro Biopharma (STRO) Posts Earnings Results, Misses Expectations By $21.10 EPS
Sutro Biopharma (NASDAQ:STRO) issued its quarterly earnings data on Wednesday. The company reported ($21.26) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.16) ...

The Bizarre And Failed Attempt To Smear Robert Mueller
In her email, the woman said she worked as a paralegal at a law firm called Pillsbury, Madison & Sutro in the early 1970s. Mueller worked at the firm after he finished law school. The Atlantic was the ...

Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
Sharp to Bring Additional Financial Expertise to Sutro's Board SAN FRANCISCO, Nov. 8, 2018 /PRNewswire/ -- Sutro Biopharma, Inc. (STRO), today announced that Shalini Sharp, Chief Financial Officer ...

Serious fire threat on Mount Sutro prompts brush clearing work
A growing fire danger on Mount Sutro has left hundreds of students and other residents, along with a 600-bed medical center, at risk. On Monday, UC San Francisco plans to begin thinning undergrowth an...

Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs
The biotech IPO train is rolling on without slowing as we head into a holiday weekend. The latest to lay the groundwork to go public are Sutro Biopharma and Arvinas, which both want Wall Street’s help ...

Sutro Biopharma Gears Up for IPO
Sutro Biopharma has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, although the offe...

Sutro Biopharma Prepares Terms For $75 Million U.S. IPO
Sutro Biopharma intends to raise at least $75 million from the sale of its common stock in a U.S. IPO. The firm is advancing a pipeline of protein therapeutics for various forms of cancer. STRO has re...